Arcutis Biotherapeutics News

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin

Dec 23 19:26 ET

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 20 17:05 ET

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin

Dec 3 16:22 ET

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Welgus Howard G.

Dec 3 16:22 ET

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru

Dec 3 16:22 ET

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Edwards Larry Todd

Dec 3 16:22 ET

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 2 16:26 ET

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Nov 26 16:23 ET

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 22 16:36 ET

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru

Nov 19 19:56 ET

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 19 16:28 ET

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Nov 18 19:10 ET

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 15 16:36 ET

Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(0.2%),Point72 Capital Advisors, Inc.(0.2%), etc.

Nov 14 19:57 ET

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 14 17:02 ET

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Curran Terrie

Nov 13 18:47 ET

Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(9.38%),David Rosen(9.38%)

Nov 13 16:37 ET

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 12 11:38 ET

Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.7%)

Nov 8 22:18 ET

Arcutis Biotherapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6 16:12 ET